{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:52:52Z","timestamp":1784328772721,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education","award":["N N401 015235"],"award-info":[{"award-number":["N N401 015235"]}]},{"DOI":"10.13039\/501100001870","name":"Foundation for Polish Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"crossref"}]},{"name":"grant nr","award":["DA009789"],"award-info":[{"award-number":["DA009789"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neuropharm.2011.11.021","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T07:55:06Z","timestamp":1323590106000},"page":"1746-1755","source":"Crossref","is-referenced-by-count":64,"title":["Spinal anandamide produces analgesia in neuropathic rats: Possible CB1- and TRPV1-mediated mechanisms"],"prefix":"10.1016","volume":"62","author":[{"given":"K.","family":"Starowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Osikowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Przewlocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.11.021_bib73","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1046\/j.1460-9568.2003.02703.x","article-title":"Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in\u00a0vitro","volume":"12","author":"Ahluwalia","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","article-title":"Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons","volume":"100","author":"Ahluwalia","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"1","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(98)00051-2","article-title":"Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury","volume":"241","author":"Bian","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3220671","article-title":"Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells","volume":"322","author":"Bisogno","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib6","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1074\/jbc.M211231200","article-title":"N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia","volume":"278","author":"Chu","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.neuroscience.2006.02.074","article-title":"Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain","volume":"139","author":"Cristino","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuroscience.2007.11.047","article-title":"Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain","volume":"151","author":"Cristino","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib10","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1074\/jbc.M008555200","article-title":"The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism","volume":"276","author":"De Petrocellis","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nn0208-124","article-title":"Why endocannabinoids are not all alike","volume":"11","author":"Di Marzo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0014-2999(00)00687-7","article-title":"Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide","volume":"406","author":"Di Marzo","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0959-4388(02)00340-9","article-title":"Endovanilloid signaling in pain","volume":"12","author":"Di Marzo","year":"2002","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.bjp.0705723","article-title":"Multiple actions of anandamide on neonatal rat cultured sensory neurones","volume":"41","author":"Evans","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/14728214.12.1.113","article-title":"Emerging drugs in neuropathic pain","volume":"12","author":"Gilron","year":"2007","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A\u00a0new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib17","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1097\/00001756-200008210-00041","article-title":"Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in\u00a0vivo","volume":"11","author":"Harris","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.bjp.0705468","article-title":"Cellular accumulation of anandamide: consensus and controversy","volume":"140","author":"Hillard","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pain.2007.04.032","article-title":"The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level","volume":"134","author":"Horvath","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib21","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib22","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.97.11.6155","article-title":"Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances","volume":"97","author":"Hwang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bja\/aef281","article-title":"Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors","volume":"89","author":"Jerman","year":"2002","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib25","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1523\/JNEUROSCI.3326-06.2006","article-title":"Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain","volume":"26","author":"Jhaveri","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(02)00637-2","article-title":"Molecular basis for species-specific sensitivity to \"hot\" chili peppers","volume":"108","author":"Jordt","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib70","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm058183t","article-title":"The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications","volume":"48","author":"Lambert","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib72","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1523\/JNEUROSCI.4071-08.2009","article-title":"Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury","volume":"29","author":"Lever","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1124\/mol.105.015644","article-title":"Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1","volume":"69","author":"Lizanecz","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib29","doi-asserted-by":"crossref","first-page":"31938","DOI":"10.1074\/jbc.M005722200","article-title":"Anandamide induces apoptosis in human cells via vanilloid receptors \u2013 evidence for a protective role of cannabinoid receptors","volume":"275","author":"Maccarrone","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib77","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.cdd.4401284","article-title":"The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis","volume":"10","author":"Maccarrone","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","volume":"16","author":"Maione","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib31","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1523\/JNEUROSCI.23-08-03136.2003","article-title":"Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors","volume":"23","author":"Marinelli","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1124\/jpet.102.043893","article-title":"Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1)","volume":"304","author":"McVey","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2009.09.030","article-title":"Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain","volume":"623","author":"Mika","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1440-1681.2007.04692.x","article-title":"Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models","volume":"34","author":"Mitchell","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib76","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1744-8069-6-94","article-title":"Ablation of rat TRPV1-expressing Adelta\/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates","volume":"6","author":"Mitchell","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","article-title":"Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain","volume":"126","author":"Mitrirattanakul","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2008.12.006","article-title":"Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain","volume":"141","author":"Obara","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","article-title":"Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain","volume":"139","author":"Osikowicz","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrn1141","article-title":"ThermoTRPs and beyond: mechanisms of temperature sensation","volume":"4","author":"Patapoutian","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib74","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.bjp.0705711","article-title":"Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide","volume":"141","author":"Price","year":"2004","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","article-title":"Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors","volume":"75","author":"Richardson","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0169-328X(02)00167-5","article-title":"Fatty acid amide hydrolase localisation in the human central nervous system: an immunohistochemical study","volume":"100","author":"Romero","year":"2002","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0703850","article-title":"Structure \u2013 activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens","volume":"132","author":"Ross","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib71","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.119941","article-title":"The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2032-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice","volume":"322","author":"Russo","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib44","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/bjp.2008.335","article-title":"Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain","volume":"155","author":"Sagar","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2005.08.005","article-title":"Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons","volume":"136","author":"Singh Tahim","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)22356-4","article-title":"The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice","volume":"270","author":"Smith","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(01)01123-2","article-title":"Temperature-Dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide","volume":"423","author":"Sprague","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2003.12.096","article-title":"Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats","volume":"358","author":"Starowicz","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib52","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1523\/JNEUROSCI.3258-07.2007","article-title":"Tonic endovanilloid facilitation of glutamate release in brainstem descending antinocice-ptive pathways","volume":"27","author":"Starowicz","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138161208783330790","article-title":"TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications","volume":"14","author":"Starowicz","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib61","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1432-1033.2004.04081.x","article-title":"Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels","volume":"271","author":"van der Stelt","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib60","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1038\/sj.emboj.7600784","article-title":"Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels","volume":"24","author":"van der Stelt","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib53","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0306-4522(02)00420-7","article-title":"Neonatal anandamide treatment results in prolonged Mitochondrial damage in the vanilloid receptor type 1-immunoreactive b-type neurons of the rat trigeminal ganglion","volume":"115","author":"Szoke","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib54","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1523\/JNEUROSCI.21-04-01104.2001","article-title":"Anandamide Excites central Terminals of dorsal root ganglion neurons via vanilloid Receptor-1 activation","volume":"21","author":"Tognetto","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/neu.20079","article-title":"Thermosensation and pain","volume":"61","author":"Tominaga","year":"2004","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(98)00700-9","article-title":"Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry","volume":"254","author":"Tsou","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib56","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.lfs.2004.10.056","article-title":"Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1","volume":"76","author":"T\u00f3th","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0083-6729(09)81015-7","article-title":"Anandamide and the vanilloid receptor (TRPV1)","volume":"81","author":"T\u00f3th","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib59","first-page":"27","article-title":"A\u00a0hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors","volume":"45","author":"Ueda","year":"1998","journal-title":"J.\u00a0Med. Invest."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(97)01342-2","article-title":"Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems","volume":"45","author":"Welch","year":"1997","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0022-3565(25)09617-X","article-title":"Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception","volume":"273","author":"Welch","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-3565(24)37725-0","article-title":"Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A","volume":"286","author":"Welch","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brainresrev.2008.12.006","article-title":"Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks","volume":"60","author":"Wong","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib66","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.11.021_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.11.021_bib68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811005004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811005004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T12:40:35Z","timestamp":1742042435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811005004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0028390811005004"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.11.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}